NEWS, REPORTS & POSITION STATEMENTS 1. NAMs for drug-induced liver injury (DILI): Where are we now ? The U.S. FDA’s National Center for Toxicological Research (NCTR) has published a new review : “New approach methodologies (NAMs) for drug-induced liver injury (DILI): Where are […]
NEWS, REPORTS & POSITION STATEMENTS 1. Nature commentary on NAMs : Alternatives to animal testing are the future A new commentary has been published in the high impact journal Nature entitled “Alternatives to animal testing are the future — it’s time that journals, […]
NEWS, REPORTS & POSITION STATEMENTS 1. Japan has joined the NAMs momentum The Japanese Pharmaceuticals and Medical Devices Agency (PMDA) has joined the New Approach Methodology (NAMs) momentum alongside the FDA with the publication of guidelines to use them in […]
NEWS, REPORTS & POSITION STATEMENTS 1. OECD : Guidance on good practices and standardisation of omics data Omics technologies are increasingly being used in regulatory toxicology as part of New Approach Methodologies (NAMs). These applications include identifying molecular points of departure for […]
NEWS, REPORTS & POSITION STATEMENTS 1. European Commission scientific strategies for sovereignty Strategy on Research and Technology Infrastructures On 15 September 2025, the EC adopted a new, long-term European Strategy on Research and Technology Infrastructures. Research infrastructures and technology infrastructures […]